NO178027C - Analogifremgangsmåte ved fremstilling av forlöpere for anti-inflammatoriske 3-acyl-2-oksindol-1-karboksamider - Google Patents

Analogifremgangsmåte ved fremstilling av forlöpere for anti-inflammatoriske 3-acyl-2-oksindol-1-karboksamider

Info

Publication number
NO178027C
NO178027C NO911512A NO911512A NO178027C NO 178027 C NO178027 C NO 178027C NO 911512 A NO911512 A NO 911512A NO 911512 A NO911512 A NO 911512A NO 178027 C NO178027 C NO 178027C
Authority
NO
Norway
Prior art keywords
oxindole
carboxamides
precursors
acyl
inflammatory
Prior art date
Application number
NO911512A
Other languages
English (en)
Norwegian (no)
Other versions
NO178027B (no
NO911512D0 (no
NO911512L (no
Inventor
Lawrence A Reiter
Thomas C Crawford
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO911512D0 publication Critical patent/NO911512D0/no
Publication of NO911512L publication Critical patent/NO911512L/no
Publication of NO178027B publication Critical patent/NO178027B/no
Publication of NO178027C publication Critical patent/NO178027C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO911512A 1988-10-18 1991-04-17 Analogifremgangsmåte ved fremstilling av forlöpere for anti-inflammatoriske 3-acyl-2-oksindol-1-karboksamider NO178027C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1988/003658 WO1990004393A1 (en) 1988-10-18 1988-10-18 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides

Publications (4)

Publication Number Publication Date
NO911512D0 NO911512D0 (no) 1991-04-17
NO911512L NO911512L (no) 1991-06-12
NO178027B NO178027B (no) 1995-10-02
NO178027C true NO178027C (no) 1996-01-10

Family

ID=22208957

Family Applications (1)

Application Number Title Priority Date Filing Date
NO911512A NO178027C (no) 1988-10-18 1991-04-17 Analogifremgangsmåte ved fremstilling av forlöpere for anti-inflammatoriske 3-acyl-2-oksindol-1-karboksamider

Country Status (33)

Country Link
US (1) US5118703A (pl)
JP (1) JPH07597B2 (pl)
KR (1) KR910007237B1 (pl)
CN (1) CN1022241C (pl)
AP (1) AP118A (pl)
AR (1) AR246519A1 (pl)
AT (1) ATE125794T1 (pl)
AU (1) AU606819B2 (pl)
BG (1) BG50834A3 (pl)
CA (1) CA1339558C (pl)
CZ (1) CZ278983B6 (pl)
DD (1) DD285604A5 (pl)
DK (1) DK514989A (pl)
EG (1) EG19887A (pl)
FI (1) FI95253C (pl)
HU (1) HU208421B (pl)
IE (1) IE66586B1 (pl)
IL (1) IL91960A (pl)
IS (1) IS1598B (pl)
MA (1) MA21657A1 (pl)
MX (1) MX18021A (pl)
MY (1) MY104238A (pl)
NO (1) NO178027C (pl)
NZ (1) NZ231044A (pl)
OA (1) OA09140A (pl)
PH (1) PH27554A (pl)
PL (2) PL162316B1 (pl)
PT (1) PT92000B (pl)
RO (1) RO109195B1 (pl)
RU (1) RU2036905C1 (pl)
SK (1) SK590689A3 (pl)
WO (1) WO1990004393A1 (pl)
YU (1) YU48070B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
DE69306595T2 (de) * 1992-11-23 1997-04-03 Pfizer Regioselektive synthese von 4-chlor-2-thiophencarbonsäure
US5270331A (en) * 1993-01-26 1993-12-14 Pfizer, Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
US5607959A (en) * 1993-02-09 1997-03-04 Pfizer Inc. Oxindole 1-[N-(alkoxycarbonyl) ] carboxamides and 1-(N-carboxamido) carboxamides as antiinflammatory agents
US5449788A (en) * 1994-01-28 1995-09-12 Catalytica, Inc. Process for preparing 2-oxindole-1-carboxamides
CN1094819C (zh) * 1997-04-30 2002-11-27 大兴株式会社 环状坯料之制造装置
EP0984012A3 (en) * 1998-08-31 2001-01-10 Pfizer Products Inc. Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
JP2003512396A (ja) * 1999-10-26 2003-04-02 ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター インドリン化合物を投与することを含む脱毛症の処置方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL96047C (pl) * 1956-06-08
US3564009A (en) * 1966-01-13 1971-02-16 Sumitomo Chemical Co Process for producing 1-acylindole derivatives
BE756447A (fr) * 1969-10-15 1971-03-22 Pfizer Oxindolecarboxamides
US3923996A (en) * 1972-07-31 1975-12-02 Sandoz Ag 3-Substituted-oxindoles in compositions and methods of treating obesity
IE53102B1 (en) * 1981-05-12 1988-06-22 Ici Plc Pharmaceutical spiro-succinimide derivatives
DE3268971D1 (en) * 1981-10-06 1986-03-20 Ici Plc Biochemical process
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4752609A (en) * 1985-06-20 1988-06-21 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
UA25898A1 (uk) * 1987-02-02 1999-02-26 Пфайзер Інк. Спосіб одержаhhя кристалічhої hатрієвої солі 5-хлор-3-(2-теhоїл)-2-оксііhдол-1-карбоксаміду
EP0365194B1 (en) * 1988-10-18 1995-08-02 Pfizer Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides

Also Published As

Publication number Publication date
RO109195B1 (ro) 1994-12-30
CA1339558C (en) 1997-11-25
NO178027B (no) 1995-10-02
JPH07597B2 (ja) 1995-01-11
AP118A (en) 1991-02-22
KR900006285A (ko) 1990-05-07
IS3509A7 (is) 1990-04-19
CN1022241C (zh) 1993-09-29
PT92000A (pt) 1990-04-30
MA21657A1 (fr) 1990-07-01
NO911512D0 (no) 1991-04-17
IL91960A (en) 1994-04-12
CN1041938A (zh) 1990-05-09
IE893332L (en) 1990-04-18
PL162316B1 (pl) 1993-09-30
NZ231044A (en) 1990-12-21
AR246519A1 (es) 1994-08-31
FI911855A0 (fi) 1991-04-17
PT92000B (pt) 1995-06-30
HU886740D0 (en) 1991-07-29
WO1990004393A1 (en) 1990-05-03
HUT58052A (en) 1992-01-28
MX18021A (es) 1993-11-01
ATE125794T1 (de) 1995-08-15
NO911512L (no) 1991-06-12
MY104238A (en) 1994-02-28
US5118703A (en) 1992-06-02
DK514989D0 (da) 1989-10-17
JPH02149559A (ja) 1990-06-08
DD285604A5 (de) 1990-12-19
FI95253C (fi) 1996-01-10
YU200589A (en) 1991-02-28
BG50834A3 (en) 1992-11-16
IE66586B1 (en) 1996-01-24
KR910007237B1 (ko) 1991-09-24
SK278175B6 (en) 1996-03-06
DK514989A (da) 1990-04-19
PL163112B1 (pl) 1994-02-28
AU4295689A (en) 1990-04-26
AP8900141A0 (en) 1989-10-31
IL91960A0 (en) 1990-07-12
IS1598B (is) 1996-05-20
YU48070B (sh) 1997-01-08
CZ278983B6 (en) 1994-11-16
HU208421B (en) 1993-10-28
RU2036905C1 (ru) 1995-06-09
OA09140A (fr) 1991-10-31
SK590689A3 (en) 1996-03-06
CZ590689A3 (en) 1994-04-13
PH27554A (en) 1993-08-18
AU606819B2 (en) 1991-02-14
FI95253B (fi) 1995-09-29
EG19887A (en) 1996-03-31

Similar Documents

Publication Publication Date Title
AU649215B1 (en) Low temperature process for the formation of ceramic coating s
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
FI875660L (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-fenyyli-2-pyrimidinonijohdannaisten valmistamiseksi
NO174101C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater
NO172540C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrrolderivater
FI875024A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1-alkyyli-6-halogeenitetrahydronaftaleenijohdannaisten valmistamiseksi
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
NO171167C (no) Analogifremgangsmaate ved fremstilling av cytidin-derivater
NO177525C (no) FremgangsmÕte for fremstilling av et kombinert anti- inflammatorisk preparat
NO914809D0 (no) Fremgangsmaate ved fremstilling av celluloseformlegemer
FI90769C (fi) Menetelmä terapeuttisesti käyttökelpoisten triatsoliyhdisteiden valmistamiseksi
NO943093D0 (no) Fremgangsmåte for fremstilling av clavulansyre
FI945441A0 (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
NO174604C (no) Fremgangsmåte ved fremstilling av relief-former
NO175478C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive diazepin-derivater
FI906408L (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
NO177496C (no) Fremgangsmåte ved fremstilling av mono-N-alkylerte polyazamakrocykler
FI881064A7 (fi) Menetelmä tulehduksenvastaisten tai analgeettisten -aminoetyylisubstituoitujen fenyyliyhdisteiden valmistamiseksi
NO874194D0 (no) Fremgangsmaate ved fremstilling av dihydro-pyridinderivater
NO178698C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
NO174774C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner
NO851758L (no) Fremgangsmaate ved fremstilling av isokinolinderivater
NO851638L (no) Fremgangsmaate ved fremstilling av iminothiazolidin-derivater